ADS-5102 provided reduction in motor complications in Parkinson’s disease patients with levodopa-induced dyskinesia switched from amantadine IR: Subgroup analysis from open-label study (ease LID 2)

著录项

• 来源
  《Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology》 |2017年第2017期|共1页
• 作者

  S. Isaacson; R. Pahwa; C. Tanner; S. Fahn; A. Espay; C. Trenkwalder; R. Patni;

  展开▼
• 作者单位

  Parkinson’s Disease and Movement Disorders Center of Boca Raton Neurology;

  University of Kansas Medical Center Neurology;

  University of California- San Francisco and San Francisco Veterans Affairs Medical Center Neurology;

  Columbia University Neurology;

  University of Cincinnati Neurology;

  Paracelsus-Elena-Klinik- Kassel and Clinic Neurosurgery- University Medical Center Neurology;

  Adamas Pharmaceuticals Medical Affairs;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 神经病学;
• 关键词